{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T15:50:58Z","timestamp":1788623458882,"version":"build-2803163510"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1038\/ncponc0400","type":"journal-article","created":{"date-parts":[[2006,1,11]],"date-time":"2006-01-11T16:38:52Z","timestamp":1136997532000},"page":"50-57","source":"Crossref","is-referenced-by-count":102,"title":["Gefitinib response of erlotinib-refractory lung cancer involving meninges\u2014role of EGFR mutation"],"prefix":"10.1038","volume":"3","author":[{"given":"Nicholas W","family":"Choong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanguy Y","family":"Seiwert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S","family":"Tretiakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya","family":"Nallasura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth C","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Lipkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliya N","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Salgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncponc0400_CR1","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1200\/JCO.2005.02.840","volume":"23","author":"RS Herbst","year":"2005","unstructured":"Herbst RS  et al. (2005) TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol 23: 5892\u20135899","journal-title":"J Clin Oncol"},{"key":"BFncponc0400_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1053\/ctrv.1999.0119","volume":"25","author":"SA Grossman","year":"1999","unstructured":"Grossman SA and Krabak MJ (1999) Leptomeningeal carcinomatosis. Cancer Treat Rev 25: 103\u2013119","journal-title":"Cancer Treat Rev"},{"key":"BFncponc0400_CR3","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1200\/JCO.2005.01.131","volume":"23","author":"MC Chamberlain","year":"2005","unstructured":"Chamberlain MC (2005) Neoplastic meningitis. J Clin Oncol 23: 3605\u20133613","journal-title":"J Clin Oncol"},{"key":"BFncponc0400_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jns.2004.05.008","volume":"223","author":"U Herrlinger","year":"2004","unstructured":"Herrlinger U  et al. (2004) Leptomeningeal metastasis: survival and prognostic factors in 155 patients. J Neurol Sci 223: 167\u2013178","journal-title":"J Neurol Sci"},{"key":"BFncponc0400_CR5","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1099314","volume":"304","author":"JG Paez","year":"2004","unstructured":"Paez JG  et al. (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304: 1497\u20131500","journal-title":"Science"},{"key":"BFncponc0400_CR6","doi-asserted-by":"publisher","first-page":"13306","DOI":"10.1073\/pnas.0405220101","volume":"101","author":"W Pao","year":"2004","unstructured":"Pao W  et al. (2004) EGF receptor gene mutations are common in lung cancers from \u201cnever smokers\u201d and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101: 13306\u201313311","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncponc0400_CR7","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","volume":"350","author":"TJ Lynch","year":"2004","unstructured":"Lynch TJ  et al. (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350: 2129\u20132139","journal-title":"N Engl J Med"},{"key":"BFncponc0400_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3816\/CLC.2004.n.026","volume":"6","author":"Y Namba","year":"2004","unstructured":"Namba Y  et al. (2004) Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases. Clin Lung Cancer 6: 123\u2013128","journal-title":"Clin Lung Cancer"},{"key":"BFncponc0400_CR9","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/annonc\/mdh276","volume":"5","author":"GL Ceresoli","year":"2004","unstructured":"Ceresoli GL  et al. (2004) Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial. Ann Oncol 5: 1042\u20131047","journal-title":"Ann Oncol"},{"key":"BFncponc0400_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.lungcan.2004.04.036","volume":"46","author":"K Hotta","year":"2004","unstructured":"Hotta K  et al. (2004) Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer. Lung Cancer 46: 255\u2013261","journal-title":"Lung Cancer"},{"key":"BFncponc0400_CR11","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1002\/cncr.21033","volume":"103","author":"AM Omuro","year":"2005","unstructured":"Omuro AM  et al. (2005) High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib. Cancer 103: 2344\u20132348","journal-title":"Cancer"},{"key":"BFncponc0400_CR12","doi-asserted-by":"publisher","first-page":"8919","DOI":"10.1158\/0008-5472.CAN-04-2818","volume":"64","author":"T Kosaka","year":"2004","unstructured":"Kosaka T  et al. (2004) Mutations of the epidermal growth factor receptor gene in lung cancer. Cancer Res 64: 8919\u20138923","journal-title":"Cancer Res"},{"key":"BFncponc0400_CR13","doi-asserted-by":"publisher","first-page":"8195","DOI":"10.1158\/1078-0432.CCR-04-1245","volume":"10","author":"SF Huang","year":"2004","unstructured":"Huang SF  et al. (2004) High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan. Clin Cancer Res 10: 8195\u20138203","journal-title":"Clin Cancer Res"},{"key":"BFncponc0400_CR14","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1056\/NEJMoa044238","volume":"352","author":"S Kobayashi","year":"2005","unstructured":"Kobayashi S  et al. (2005) EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med 352: 786\u2013792","journal-title":"N Engl J Med"},{"key":"BFncponc0400_CR15","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1371\/journal.pmed.0020073","volume":"2","author":"W Pao","year":"2005","unstructured":"Pao W  et al. (2005) Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med 2: e73","journal-title":"PLoS Med"},{"key":"BFncponc0400_CR16","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1158\/0008-5472.CAN-04-2650","volume":"65","author":"PC Ma","year":"2005","unstructured":"Ma PC  et al. (2005) Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer. Cancer Res 65: 1479\u20131488","journal-title":"Cancer Res"}],"container-title":["Nature Clinical Practice Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncponc0400.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncponc0400","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncponc0400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncponc0400.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:41:07Z","timestamp":1684442467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncponc0400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["BFncponc0400"],"URL":"https:\/\/doi.org\/10.1038\/ncponc0400","relation":{},"ISSN":["1743-4254","1743-4262"],"issn-type":[{"value":"1743-4254","type":"print"},{"value":"1743-4262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}